ChemicalBook >> CAS DataBase List >>alpha-Helical CRF (9-41)

alpha-Helical CRF (9-41)

CAS No.
99658-03-4
Chemical Name:
alpha-Helical CRF (9-41)
Synonyms
alpha-Helical CRF (9-41);CORTICOTROPIN RELEASING FACTOR ANTAGONIST;α-Helical CRF (9-41) trifluoroacetate salt;ALPHA-HELICAL CORTICOTROPIN RELEASING FA CTOR;Alpha-Helical CRF (9-41) trifluoroacetate salt;α-Helical Corticotropin Releasing Factor (9-41);ALPHA-CORTICOTROPIN-RELEASING FACTOR 9-41, HELICAL;ALPHA-HELICAL CORTICOTROPIN RELEASING FACTOR (9-41);alpha-Helical corticotropin releasing factor fragment;α-helical corticotropin releasing factor fragment (9-41)
CBNumber:
CB1103870
Molecular Formula:
C22H25IN2O6
Molecular Weight:
540.34817
MDL Number:
MFCD00081543
MOL File:
99658-03-4.mol
Last updated:2026-09-12 18:48:34

alpha-Helical CRF (9-41) Properties

storage temp. −20°C
form powder
color white
UNSPSC Code 51111800
NACRES NA.32

SAFETY

Risk and Safety Statements

PPE Eyeshields, Gloves, type N95 (US)
WGK Germany  3
Storage Class 11 - Combustible Solids

alpha-Helical CRF (9-41) price More Price(15)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich C2917 Corticotropin Releasing Factor Antagonist ≥97% (HPLC) 99658-03-4 0.1mg $171 2026-04-30 Buy
Biosynth FH108583 Alpha-Helical CRF (9-41) trifluoroacetate salt 99658-03-4 500ug $900 2026-06-04 Buy
Biosynth FH108583 Alpha-Helical CRF (9-41) trifluoroacetate salt 99658-03-4 250ug $900 2026-06-04 Buy
Biosynth FH108583 Alpha-Helical CRF (9-41) trifluoroacetate salt 99658-03-4 100ug $900 2026-06-04 Buy
Biosynth FH108583 Alpha-Helical CRF (9-41) trifluoroacetate salt 99658-03-4 1000ug $1440 2026-06-04 Buy
Product number Packaging Price Buy
C2917 0.1mg $171 Buy
FH108583 500ug $900 Buy
FH108583 250ug $900 Buy
FH108583 100ug $900 Buy
FH108583 1000ug $1440 Buy

alpha-Helical CRF (9-41) Chemical Properties, Uses, Production

Uses

α-Helical Corticotropin Releasing Factor (9-41) is a corticotropin releasing factor (CRF) antagonist. α-Helical Corticotropin Releasing Factor (9-41) decreases plasma growth hormone (GH) values in vivo[1][2].

Biochem/physiol Actions

The corticotropin releasing factor (CRF) antagonist α-helical CRF [9-41] exhibits 10-fold higher affinity for rat CRF2α receptors over human CRF2α receptors. It has been used to elucidate the role of CRF in various physiological systems. In colonic epithelium, it abolishes CRF-induced changes in ion secretion, and significantly inhibits CRF-stimulated conductance. It antagonizes the CRF-induced proinflammatory degranulation of perivascular mast cells that are activated in response to acute psychological stress and CRF secretion.

in vivo

α-Helical Corticotropin Releasing Factor (9-41) (10 μg; the third or lateral ventricle of the brain injection; once) significantly decreases plasma GH values[1]. α-Helical Corticotropin Releasing Factor (9-41) (100 ng/kg; i.c.v. once) affects rhlL-1/β-induced enhancement of the splenic sympathetic activity[2].

Animal Model:Adult Sprague-Dawley rats[1]
Dosage:10 μg
Administration:The third or lateral ventricle of the brain injection; 10 μg once
Result:Abolished the 10 min electroshocks-produced the decreasing of plasma GH levels by injected into the third or lateral ventricle of the brain 45 min before exposure to stress.
Animal Model:Adult Sprague-Dawley rats with immunity of endogenous somatostatin (SS)[1]
Dosage:10 μg
Administration:Lateral ventricle brain injection; 10 μg once
Result:Showed no effect on plasma GH values in rats whose endogenous SS had been immunoneutralized, but did interfere with the stimulatory effect of GH-releasing factor (GRF).
Animal Model:Male Wistar rats with rhlL-1/β injection[2]
Dosage:100 ng/kg
Administration:Intracerebroventricularly injection; 100 ng/kg once
Result:Completely blocked the rhlL-1/β-induced enhancement of the splenic sympathetic activity, but failed to alter the enhancement of nociceptive behaviors caused by rhlL-1/β.

References

[1] Rivier C, Vale W. Involvement of corticotropin-releasing factor and somatostatin in stress-induced inhibition of growth hormone secretion in the rat. Endocrinology. 1985 Dec;117(6):2478-82. DOI:10.1210/endo-117-6-2478
[2] Takakazu Oka, et al. Intracerebroventricular injection of interleukin-1/β induces hyperalgesia in rats. Brain Research, 624 (1993) 61-68.

alpha-Helical CRF (9-41) Preparation Products And Raw materials

Raw materials

Preparation Products

alpha-Helical CRF (9-41) Suppliers

Global Suppliers ( 55)
Supplier Tel Email Country ProdList Advantage
3B Pharmachem (Wuhan) International Co.,Ltd. 18930552037 3bsc@sina.com China 15813 69
Shanghai Hanhong Scientific Co.,Ltd. 021-54306202 13764082696 info@hanhongsci.com China 42917 64
Chemsky(shanghai)International Co.,Ltd. 021-50135380 shchemsky@sina.com China 32273 50
Hunan Hui Bai Shi Biotechnology Co., Ltd. 0731-85526065 13308475853 ivy@hnhbsj.com China 7236 62
Wuxi Zhongkun Biochemical Technology Co., Ltd. 0510-85629785 18013409632; sales@reading-chemicals.com China 15165 58
Sigma-Aldrich 021-61415566 800-8193336 orderCN@merckgroup.com China 51389 80
Nanjing Leon Biological Technology Co., Ltd. 025-84523390 -127; 17705183659 sales@njleonbiotech.com China 5501 55
Nanjing Peptide Biotech Ltd. 025-58361106-805 15951641583 zhao.xu@njpeptide.com China 9976 55
Chengdu Youngshe Chemical Co., Ltd. +86-17380623303 Caroline@youngshechem.com China 4725 58
Hangzhou Peptidego Biotech Co.,Ltd. 0571-87213919 15967184799 Eric@peptidego.com China 7872 58
CORTICOTROPIN RELEASING FACTOR ANTAGONIST H-ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-GLU-MET-LEU-GLU-MET-ALA-LYS-ALA-GLU-GLN-GLU-ALA-GLU-GLN-ALA-ALA-LEU-ASN-ARG-LEU-LEU-LEU-GLU-GLU-ALA-NH2 ASP-LEU-THR-PHE-HIS-LEU-ARG-GLU-MET-LEU-GLU-MET-ALA-LYS-ALA-GLU-GLN-ALA-GLU-GLN-ALA-LEU-ASN-ARG-LEU-LEU-GLU-ALA-NH2 ASP-LEU-THR-PHE-HIS-LEU-LEU-ARG-GLU-MET-LEU-GLU-MET-ALA-LYS-ALA-GLU-GLN-GLU-ALA-GLU-GLN-ALA-ALA-LEU-ASN-ARG-LEU-LEU-LEU-GLU-GLU-ALA-NH2 ALPHA-HELICAL CORTICOTROPIN RELEASING FA CTOR α-helical corticotropin releasing factor fragment (9-41) ALPHA-HELICAL CORTICOTROPIN RELEASING FACTOR (9-41) ALPHA-HELICAL CORTICOTROPIN RELEASING FACTOR FRAGMENT (9-41) ALPHA-CORTICOTROPIN-RELEASING FACTOR 9-41, HELICAL alpha-Helical corticotropin releasing factor fragment methyl (2S)-2-[[(3R)-3-hydroxy-4-(phenylmethoxycarbonylamino)butanoyl]amino]-3-(2-iodophenyl)propanoate L-α-Aspartyl-L-leucyl-L-threonyl-L-phenylalanyl-L-histidyl-L-leucyl-L-leucyl-L-arginyl-L-α-glutamyl-L-methionyl-L-leucyl-L-α-glutamyl-L-methionyl-L-alanyl-L-lysyl-L-alanyl-L-α-glutamyl-L-glutaminyl-L-α-glutamyl-L-alanyl-L-α-glutamyl-L-glutaminyl-L-alanyl-L-alanyl-L-leucyl-L-asparaginyl-L-arginyl-L-leucyl-L-leucyl-L-leucyl-L-α-glutamyl-L-α-glutamyl-L-alanine α-Helical CRF (9-41) trifluoroacetate salt alpha-Helical CRF (9-41) |alpha|a-Helical Corticotropin Releasing Factor (9-41) Alpha-Helical CRF (9-41) trifluoroacetate salt α-Helical Corticotropin Releasing Factor (9-41) alpha-Helical CRF (9-41) 99658-03-4 C166H273N45O54S2 C22H25IN2O6 CRF Other Peptides Peptides Releasing Factors Biochemicals and Reagents BioChemical Amino Acids and Peptides CRF receptor and related